Its expression is potently upregulated in muscle in response to proinflammatory mediators present during acute exacerbation of COPD (including cytokines such as IL-1β and TNF-α), as well as by alternative factors implicated in COPD muscle wasting such as hypoxia and fasting (15–17). The gene discussed is IL1B; the disease is chronic obstructive pulmonary disease.